281 related articles for article (PubMed ID: 21750605)
41. Glial remodeling and neural plasticity in human retinal detachment with proliferative vitreoretinopathy.
Sethi CS; Lewis GP; Fisher SK; Leitner WP; Mann DL; Luthert PJ; Charteris DG
Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):329-42. PubMed ID: 15623793
[TBL] [Abstract][Full Text] [Related]
42. Expression of wild-type p53-induced phosphatase 1 in diabetic epiretinal membranes.
Xu J; Zhong H; Cui L; Lan Q; Chen L; He W; Wu Y; Jiang L; Huang H; Zhao X; Li L; Zeng S; Li M; Xu F
Oncotarget; 2017 May; 8(22):35532-35541. PubMed ID: 28402943
[TBL] [Abstract][Full Text] [Related]
43. Analysis of the molecular biologic milieu of the vitreous in proliferative vitreoretinopathy.
Wladis EJ; Falk NS; Iglesias BV; Beer PM; Gosselin EJ
Retina; 2013 Apr; 33(4):807-11. PubMed ID: 23222459
[TBL] [Abstract][Full Text] [Related]
44. Immunocytochemical and ultrastructural evidence of glial cells and hyalocytes in internal limiting membrane specimens of idiopathic macular holes.
Schumann RG; Eibl KH; Zhao F; Scheerbaum M; Scheler R; Schaumberger MM; Wehnes H; Walch AK; Haritoglou C; Kampik A; Gandorfer A
Invest Ophthalmol Vis Sci; 2011 Oct; 52(11):7822-34. PubMed ID: 21900375
[TBL] [Abstract][Full Text] [Related]
45. Assessment of the integrin alpha5beta1 antagonist JSM6427 in proliferative vitreoretinopathy using in vitro assays and a rabbit model of retinal detachment.
Zahn G; Volk K; Lewis GP; Vossmeyer D; Stragies R; Heier JS; Daniel PE; Adamis AP; Chapin EA; Fisher SK; Holz FG; Löffler KU; Knolle J
Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):1028-35. PubMed ID: 19815730
[TBL] [Abstract][Full Text] [Related]
46. Experimental Modeling of Proliferative Vitreoretinopathy. An Experimental Morphological Study.
Khoroshilova-Maslova IP; Leparskaya NL; Nabieva MM; Andreeva LD
Bull Exp Biol Med; 2015 May; 159(1):100-2. PubMed ID: 26033599
[TBL] [Abstract][Full Text] [Related]
47. [Alterations in the structure of the epiretinal membranes in PVR -- assumptions and reality].
Vidinova C; Voinov L; Vidinov N
Klin Monbl Augenheilkd; 2005 Jul; 222(7):568-71. PubMed ID: 16034724
[TBL] [Abstract][Full Text] [Related]
48. Septin expression in proliferative retinal membranes.
Xin X; Pache M; Zieger B; Bartsch I; Prünte C; Flammer J; Meyer P
J Histochem Cytochem; 2007 Nov; 55(11):1089-94. PubMed ID: 17625225
[TBL] [Abstract][Full Text] [Related]
49. Single-Cell Protein and Transcriptional Characterization of Epiretinal Membranes From Patients With Proliferative Vitreoretinopathy.
Laich Y; Wolf J; Hajdu RI; Schlecht A; Bucher F; Pauleikhoff L; Busch M; Martin G; Faatz H; Killmer S; Bengsch B; Stahl A; Lommatzsch A; Schlunck G; Agostini H; Boneva S; Lange C
Invest Ophthalmol Vis Sci; 2022 May; 63(5):17. PubMed ID: 35579905
[TBL] [Abstract][Full Text] [Related]
50. The role of cytokines and trophic factors in epiretinal membranes: involvement of signal transduction in glial cells.
Harada C; Mitamura Y; Harada T
Prog Retin Eye Res; 2006 Mar; 25(2):149-64. PubMed ID: 16377232
[TBL] [Abstract][Full Text] [Related]
51. Different expression of vascular endothelial growth factor and pigment epithelium-derived factor between diabetic and non-diabetic epiretinal membranes.
Nam DH; Oh J; Roh JH; Huh K
Ophthalmologica; 2009; 223(3):188-91. PubMed ID: 19182495
[TBL] [Abstract][Full Text] [Related]
52. Apelin in epiretinal membranes of patients with proliferative diabetic retinopathy.
Lu Q; Ma Y; Xu YS; Jiang YR
Mol Vis; 2014; 20():1122-31. PubMed ID: 25324682
[TBL] [Abstract][Full Text] [Related]
53. Epithelial-mesenchymal transition in proliferative vitreoretinopathy: intermediate filament protein expression in retinal pigment epithelial cells.
Casaroli-Marano RP; Pagan R; Vilaró S
Invest Ophthalmol Vis Sci; 1999 Aug; 40(9):2062-72. PubMed ID: 10440262
[TBL] [Abstract][Full Text] [Related]
54. The role of thrombin in proliferative vitreoretinopathy.
Bastiaans J; van Meurs JC; Mulder VC; Nagtzaam NM; Smits-te Nijenhuis M; Dufour-van den Goorbergh DC; van Hagen PM; Hooijkaas H; Dik WA
Invest Ophthalmol Vis Sci; 2014 Jul; 55(7):4659-66. PubMed ID: 25015355
[TBL] [Abstract][Full Text] [Related]
55. Localisation of opticin in human proliferative retinal disease.
Pattwell DM; Sheridan CM; Le Goff M; Bishop PN; Hiscott P
Exp Eye Res; 2010 Mar; 90(3):461-4. PubMed ID: 20036236
[TBL] [Abstract][Full Text] [Related]
56. uPA, tPA and PAI-1 mRNA expression in periretinal membranes.
Sirén V; Immonen I
Curr Eye Res; 2003 Nov; 27(5):261-7. PubMed ID: 14562162
[TBL] [Abstract][Full Text] [Related]
57. Atrial natriuretic peptide in the vitreous humor and epiretinal membranes of patients with proliferative diabetic retinopathy.
Rollin R; Mediero A; Martínez-Montero JC; Roldán-Pallarés M; Suárez-Leoz M; Vidal-Fernández P; Cortés-Valdés C; Fernández-Cruz A; Fernández-Durango R
Mol Vis; 2004 Jul; 10():450-7. PubMed ID: 15273657
[TBL] [Abstract][Full Text] [Related]
58. Pathological vitreous causes cell line-derived (but not donor-derived) retinal pigment epithelial cells to display proliferative vitreoretinopathy-like features in culture.
Sharma M; Tiwari A; Sharma S; Bansal R; Gupta V; Gupta A; Luthra-Guptasarma M
Clin Exp Ophthalmol; 2014 Nov; 42(8):745-60. PubMed ID: 24612444
[TBL] [Abstract][Full Text] [Related]
59. A sustained dual drug delivery system for proliferative vitreoretinopathy.
Xiao Y; Choi KS; Warther D; Huffman K; Landeros S; Freeman WR; Sailor MJ; Cheng L
Drug Deliv; 2020 Dec; 27(1):1461-1473. PubMed ID: 33100053
[TBL] [Abstract][Full Text] [Related]
60. Induction of proliferative vitreoretinopathy by a unique line of human retinal pigment epithelial cells.
Wong CA; Potter MJ; Cui JZ; Chang TS; Ma P; Maberley AL; Ross WH; White VA; Samad A; Jia W; Hornan D; Matsubara JA
Can J Ophthalmol; 2002 Jun; 37(4):211-20. PubMed ID: 12095094
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
